House Dust Mite, Dermatophagoides pteronyssinus is a Cutaneous; Intradermal; Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Allermed Laboratories, Inc.. The primary component is Dermatophagoides Pteronyssinus.
| Product ID | 49643-704_5664e19e-6019-4b8b-b2d0-c349910bcf07 |
| NDC | 49643-704 |
| Product Type | Human Prescription Drug |
| Proprietary Name | House Dust Mite, Dermatophagoides pteronyssinus |
| Generic Name | House Dust Mite, Dermatophagoides Pteronyssinus |
| Dosage Form | Injection |
| Route of Administration | CUTANEOUS; INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1986-12-24 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102213 |
| Labeler Name | Allermed Laboratories, Inc. |
| Substance Name | DERMATOPHAGOIDES PTERONYSSINUS |
| Active Ingredient Strength | 10000 [AU]/mL |
| Pharm Classes | Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [CS],Insect Proteins [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |